Literature DB >> 7263191

Continuous high-dose intravenous desferrioxamine treatment for iron overload.

Y Sidi, M Shaklai, E Liban, J Pinkhas.   

Abstract

We describe a patient with heavy posttransfusion iron overload, to whom continuous high-dose i.v. desferrioxamine was administered shortly before his death. The administration of nearly 500 g of this agent was followed by urinary excretion of 5.4 g of iron. The chelator therapy lost its efficiency in the last of five courses and the patient eventually died as a result of cardiac and hepatic damage related to iron overload. The theoretical and practical implications of these observations are discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7263191

Source DB:  PubMed          Journal:  Isr J Med Sci        ISSN: 0021-2180


  2 in total

1.  Susceptibilities of bacterial and fungal urinary tract isolates to desferrioxamine.

Authors:  F D Lowy; S Pollack; N Fadl-Allah; N H Steigbigel
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

2.  High dosage desferrioxamine therapy in a female patient with acquired aplastic anaemia and transfusion siderosis.

Authors:  H Breithaupt; H Heckers; H Pralle; W Guttmann; H Bleyl; V Graef; G Jundt
Journal:  Blut       Date:  1986-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.